-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
Helping each other regulate clinical trials: a network of vaccine regulators from developing countries
Sergio A Nishioka, James Southern, Rolando Dominguez, Nora Dellepiane
Research Update: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Randomized dose-finding studies: how many dose levels should be used?
Yinghui Zhou
Editorial: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation